Home JournalsJournal Details

ISSN: 1574-0153 eISSN: 1875-8592 CAS Zone: Medicine (Zone 4) Emerging Zone: Medicine (Zone 4) No

Cancer Biomarkers

Abbr. CANCER BIOMARK ·NETHERLANDS ·Frequency Bimonthly ·Avg. articles/yr 129 articles

1.8

Latest IF

2.00%

Self-citation

约50%

Submission difficulty

Avg. 3.0 months

Review cycle

About Journal

Cancer Biomarkers (ISSN 1574-0153) is a specialized international journal published by IOS Press in the Netherlands, dedicated to advancing the discovery, validation, and clinical application of biomarkers in oncology. As a bimonthly publication indexed in the Science Citation Index (SCI), the journal serves as a critical academic platform for researchers investigating molecular, genetic, proteomic, and metabolomic markers that enhance cancer diagnosis, prognosis, and therapeutic strategies. While its impact factor may fluctuate annually and its non-open access model can limit immediate reader accessibility, the journal maintains a strong reputation for publishing high-quality research within the Chinese Academy of Sciences journal ranking system. By focusing on this frontier area of biomedical science, Cancer Biomarkers attracts rigorous submissions from a global community, offering a competitive yet respected venue for scholars seeking to contribute to the precision medicine landscape in cancer care.

Recent Articles

Retraction notice: AnnexinA7 down-regulation might suppress the proliferation and metastasis of human hepatocellular carcinoma cells via MAPK/ ERK pathway

Vol 43

2026-09-10

Retraction Notice: Identification of GOLM1 as a positively regulator of tumor metastasis by regulating MMP13 in gastric carcinoma

Vol 43

2026-09-03

Retraction notice: Reduced EphB6 protein in gastric carcinoma and associated lymph nodes suggests EphB6 as a gastric tumor and metastasis inhibitor

Vol 43

2026-09-03

Retraction notice: Glutamate dehydrogenase inhibits tumor growth in gastric cancer through the notch signaling pathway

Vol 43

2026-09-03

Identification of a cholesterol metabolism-related signature based on KIF20A and NDC80 for prognostic stratification and immunotherapy prediction in hepatocellular carcinoma

Yan Y, Liu Z, Zhou D et al · Vol 43

2026-09-02

Integrated multiparametric ultrasound and biomarker assessment for clinical staging and treatment response prediction in cervical cancer: A single-center retrospective study

Lyu T, Li M, Li H et al · Vol 43

2026-08-22

Collagen turnover biomarkers as diagnostic, prognostic, and therapy monitoring indicators in gastric cancer

Kaps L, Genc M, Möhler M et al · Vol 43

2026-08-21

Retraction: Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-1/ Smad signaling pathway

Vol 43

2026-08-03

Evaluation of radiomics and radiologic signatures for diagnosis and clinical outcomes in pancreatic adenocarcinoma and pancreatic neuroendocrine: A pilot study

Martin R, Fromer M, Gordon J et al · Vol 43

2026-07-17

Risk-stratification potential of inflammatory and nutritional biomarkers in gastric cancer: Insights from a propensity score-matched analysis

Demircioglu M, Demircioglu Z, Akca M · Vol 43

2026-07-16

Gene expression profiling of ovarian cancer reveals candidate diagnostic and prognostic biomarkers: An integrated bioinformatics approach

Woode M, Appah M, Alhassan E et al · Vol 43

2026-07-14

A novel diagnostic model for early-stage high-grade serous ovarian cancer based on serum tRNA-derived fragments

Zhao X, Wen W, Jia Y et al · Vol 43

2026-07-11

A causal association between Epstein-Barr virus infection and lung cancer: A two-sample Mendelian Randomization study

Wang J, Wang K, Wang Z · Vol 43

2026-07-04

In silico analysis suggests ELL2 as a survival-associated cross-tissue biomarker in gastric cancer

Zare K, Salehi Z, Morovat A et al · Vol 43

2026-06-23

The clinical assessment of miR-34a and miR-135b panel as promising diagnostic biomarkers predict the risk of colorectal cancer: A case-control study

Karami R, Najafi E, Babaei A et al · Vol 43

2026-06-10

Integrative multi-omics analysis-based Mendelian randomization identifies association of DNA repair–related genes with oral cancer

Wang J, Tang W, Ding W et al · Vol 43

2026-06-08

Stage-specific biomarkers in triple-negative breast cancer: Preliminary findings from bioinformatics approaches

Shahraki F, Meshkini A, Nazari E · Vol 43

2026-05-28

Development and verification of cell cycle-related gene markers for prognosis in bladder cancer

Li H, Zhu D · Vol 43

2026-05-20

Detection of methylated SEPT9 DNA in peripheral blood for diagnosis of colorectal cancer

Lin M, Chen H, Jiang C · Vol 43

2026-05-07

Bidirectional Mendelian randomization analysis reveals significant associations between Serum DNA repair proteins and liver cancer

Lin S, Fang K, Geng L · Vol 43

2026-04-22

Journal Info

ISSN

1574-0153

Abbr.

CANCER BIOMARK

Region

NETHERLANDS

Frequency

Bimonthly

CAS Zone

Medicine (Zone 4) · Non-Top

Emerging Zone

Medicine (Zone 4) · Non-Top

Open Access

No

Research Area

ONCOLOGY -

Coverage

Science Citation Index Expanded

Sub-categories

ONCOLOGYZone 4

Emerging Categories

ONCOLOGYZone 4

Submission & Homepage

Submit Homepage

Analysis Services

Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.

Business Email

E-mail: product@genelibs.com